How I treat Logo
howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Bone Marrow Stimulants

 

 Name    

Dose 

(Adults) 

 Dose

(Paediatric)

Precautions 

Erythropoietin 3000-15000 units- 3 times a week- SC 50-100IU/kg- Thrice a week

 Adjust the dose as per response. Hold if Hb >10 (as this can cause VTE/ stroke), Monitor BP, avoid in uncontrolled hypertension. W/F PRCA, Seizures

Ensure adequate iron stores

Darbapoietin 25-300mcg- SC- Once a week 

 Adjust the dose as per response. Hold if Hb >10 (as this can cause VTE/ stroke), Monitor BP, avoid in uncontrolled hypertension. W/F PRCA, Seizures

Ensure adequate iron stores

 G-CSF 300mcg- OD- SC 5mcg/kg- OD- SCGive till TLC>3500/cmm, W/F- Bone pains, diarrhea, fever
Peg-G-CSF6mg- SC- Stat Given after completion of chemo, where there is anticipated neutropenia
 Eltrombopag 50mg- OD- at 4 am Adjust the dose to maintain platelet count just above 50,000/cmm.
Monitor LFT, Decrease dose SOS
Avoid with Iron, aluminium and magnesium salts.
Romiplostin1microgram/Kg- SC- once a week. Increase the dose by 1microgram/Kg every week with target platelet count of 50,000/cmm  

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo
howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.